<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for TTHI</title>
    <link />
    <description>Headlines for Transition Therapeutics Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Eli Lilly to Take Over Development of Diabetes Drug</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/eli-lilly-to-take-over-development-of-diabetes-dru/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 11:38:00 GMT</pubDate>
    </item>
    <item>
      <title>Good News For This Small-Cap Biotech: Eli Lilly Wants To Develop Its Diabetes Drug</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1505432-good-news-for-this-small-cap-biotech-eli-lilly-wants-to-develop-its-diabetes-drug.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 11:00:15 GMT</pubDate>
    </item>
    <item>
      <title>Transition to Get $7 Million as Lilly to Assume Rights to TT-401</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130617-000091&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Mon, 17 Jun 2013 06:53:59 GMT</pubDate>
    </item>
    <item>
      <title>Transition Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1411311-transition-therapeutics-management-discusses-q3-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 18:10:06 GMT</pubDate>
    </item>
    <item>
      <title>Transition Therapeutics Still Undervalued: Good Trial Outcome Shifts Focus To Lilly Decision</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1385571-transition-therapeutics-still-undervalued-good-trial-outcome-shifts-focus-to-lilly-decision.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 30 Apr 2013 14:52:58 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130430-000292&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 30 Apr 2013 09:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Transition Therapeutics Shares Sharply Higher as Data from TT-401 in Type 2 Diabetes Better Than Exp</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3542112/transition-therapeutics-shares-sharply-higher-as-data-from-tt-401-in-type-2-diabe.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 30 Apr 2013 08:21:28 GMT</pubDate>
    </item>
    <item>
      <title>Transition Therapeutics To Trade Higher Into Upcoming Trial Results For Diabetes Drug</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1137121-transition-therapeutics-to-trade-higher-into-upcoming-trial-results-for-diabetes-drug.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 28 Jan 2013 09:47:47 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $5 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-under-5-making-big-moves.html-5.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Thu, 20 Sep 2012 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Transition Therapeutics Awaiting Competing AD Trial Results</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/725551-transition-therapeutics-awaiting-competing-ad-trial-results.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 17 Jul 2012 07:26:34 GMT</pubDate>
    </item>
    <item>
      <title>Elan, Lonza in Supply Deal - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2011-12/elan-lonza-in-supply-deal-analyst-blog.aspx.aspx?storyid=106888&amp;source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 05 Dec 2011 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Life Sciences Companies Raise Record Amounts of Capital</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/244319-life-sciences-companies-raise-record-amounts-of-capital.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 31 Dec 2010 16:37:04 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Transition Halts Development Of Lead Diabetes Drug</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20100917-000433&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 17 Sep 2010 11:51:00 GMT</pubDate>
    </item>
    <item>
      <title>Transition Halts Development Of Lead Diabetes Candidate</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/ON/.aspx?story=ON-20100917-000323&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 17 Sep 2010 06:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Transition Buys Rights To Eli Lilly Diabetes Compounds</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20100303-000360&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 03 Mar 2010 06:46:00 GMT</pubDate>
    </item>
  </channel>
</rss>
